Windtree Therapeutics
(NASDAQ:WINT)
$0.365
-0.0029[-0.79%]
At close: Mar 28
$0.365
0[0.00%]
After Hours: 4:18PM EDT
Consensus Rating1
Outperform
Highest Price Target1
$8.00
Lowest Price Target1
$1.00
Consensus Price Target1
$4.50

Windtree Therapeutics Stock (NASDAQ:WINT), Analyst Ratings, Price Targets, Predictions

Windtree Therapeutics Inc has a consensus price target of $4.5, established from looking at the 2 latest analyst ratings. The last 2 analyst ratings were released from HC Wainwright & Co. and Oppenheimer on January 3, 2024 and June 4, 2021. With an average price target of $4.5 between HC Wainwright & Co. and Oppenheimer, there's an implied 1132.88% upside for Windtree Therapeutics Inc from these 2 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Jan
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Oppenheimer

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Windtree Therapeutics

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
01/03/2024WINTBuy Now
Windtree Therapeutics
$0.36173.97%HC Wainwright & Co.
Vernon Bernardino
→ $1Initiates → NeutralGet Alert
06/04/2021WINTBuy Now
Windtree Therapeutics
$0.362091.78%Oppenheimer
Leland Gershell
Initiates → OutperformGet Alert

FAQ

Q

What is the target price for Windtree Therapeutics (WINT)?

A

The latest price target for Windtree Therapeutics (NASDAQ: WINT) was reported by HC Wainwright & Co. on January 3, 2024. The analyst firm set a price target for $1.00 expecting WINT to rise to within 12 months (a possible 173.97% upside). 1 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Windtree Therapeutics (WINT)?

A

The latest analyst rating for Windtree Therapeutics (NASDAQ: WINT) was provided by HC Wainwright & Co., and Windtree Therapeutics initiated their neutral rating.

Q

When was the last upgrade for Windtree Therapeutics (WINT)?

A

There is no last upgrade for Windtree Therapeutics.

Q

When was the last downgrade for Windtree Therapeutics (WINT)?

A

There is no last downgrade for Windtree Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Windtree Therapeutics (WINT)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Windtree Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Windtree Therapeutics was filed on January 3, 2024 so you should expect the next rating to be made available sometime around January 3, 2025.

Q

Is the Analyst Rating Windtree Therapeutics (WINT) correct?

A

While ratings are subjective and will change, the latest Windtree Therapeutics (WINT) rating was a initiated with a price target of $0.00 to $1.00. The current price Windtree Therapeutics (WINT) is trading at is $0.37, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch